Real-time financial, economic, and global news with market-focused context and analysis.
Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.
UBS raised its price target on Texas Instruments (TXN) to $260 from $245 and kept a Buy rating, citing stronger revenue trends, improved bookings and constructive backlog commentary. UBS also designated TXN a Top Pick for 2026 and flagged rising free cash flow potential. The stock is trading near $196.63, while other analysts such as Mizuho have ad…
GE Vernova on Wednesday raised its revenue outlook for 2026 to a range of $44 billion to $45 billion, topping the average analyst estimate of $41.97 billion. The company reported a 34% jump in quarterly orders to $59.3 billion and saw sizable gains in core profits for its electrification and power segments, driven by rising demand from data centers…
UBS increased its price target for Boeing to $285 from $275 while maintaining a Buy rating, pointing to improving free cash flow and management's emphasis on quality and stability as production ramps. Boeing reported a robust fourth quarter with earnings and revenue that beat expectations, prompting several other analysts to raise their targets.
UBS raised its price objective on RTX to $208 from $199 while retaining a Neutral recommendation after the company reported strong fourth-quarter results. The investment bank pointed to better-than-expected free cash flow in 2025 and 2026 guidance, margin progress across RTX’s businesses and improvements in core cash generation despite higher capit…
UBS increased its 12-month price target on UPS to $125 from $116 while retaining a Buy recommendation, even as it reduced its Q1 earnings-per-share estimate because of near-term margin pressures. UBS and other analysts expect margin headwinds to ease through 2026, with a notable improvement anticipated in the domestic package business in the second…
UBS increased its price target on Nextpower (NXT) to $140 from $125 and kept a Buy rating, citing the company’s leading position in solar trackers, strong customer relationships and its shift toward a broader electric hardware platform. The upgrade follows robust quarterly results and additional positive analyst actions from JPMorgan and KeyBanc, r…
The dollar steadied on Wednesday following a steep decline to a four-year low overnight, a move that President Donald Trump publicly welcomed as the currency being "great" and that it should "just seek its own level." Markets are weighing whether the administration prefers a weaker dollar while Treasury Secretary Scott Bessent has remained tight-li…
On Jan. 28, Eikon Therapeutics filed to pursue a U.S. initial public offering that would value the company at as much as $908.2 million and raise up to $317.7 million by selling 17.65 million shares at $16 to $18 apiece. The Millbrae, California-based drug developer is advancing a cancer pipeline led by EIK1001, being evaluated in combination with …
On Jan 28 the FTSE 100 declined as losses in healthcare and bank shares offset gains in miners and energy names. The domestically focused FTSE 250 rose, hitting its highest level since January 2022 earlier in the session. Market attention centred on corporate earnings and an awaited U.S. Federal Reserve policy update.
Bank of America reported that its clients were net buyers of U.S. equities last week for the first time in eight weeks, with single-stock inflows driving the shift. Buying was widespread across client categories, sector flows favored Communication Services and Technology, and ETF activity was mixed - equity ETF outflows contrasted with fixed-income…
UBS downgraded Finnish renewable fuels producer Neste to Neutral from Buy, citing a roughly 30% share-price rise over the past two months that it says already reflects a more favorable regulatory backdrop. The broker lifted its price target modestly but says upside from current levels appears limited, and expects mixed near-term results as maintena…
Relay Therapeutics is catching a bid as optimism builds around zovegalisib (RLY-2608). With shares back near the top of the 52-week range and short interest still heavy, the next move likely comes down to whether price can hold above key moving averages and push through recent resistance. Here’s a defined long trade with a tight invalidation level …
Walmart has reclassified 3,000 pharmacy technician positions to operations team lead roles, raising the average hourly pay for those roles and expanding top-end wage eligibility for pharmacy technicians as it grows digital healthcare services and delivery options across its 4,600 stores. The move coincides with competitive pressure in the pharmacy …
AT&T said it expects 2026 adjusted earnings per share to exceed analyst forecasts, attributing the upbeat outlook to planned network investments including the acquisition of Lumen’s consumer fiber assets and EchoStar’s spectrum licenses. The company reported healthy fiber and wireless additions in the fourth quarter and will consolidate 5G and fibe…
China’s Foreign Minister Wang Yi told Emmanuel Bonne, the diplomatic adviser to the French president, that China and the European Union are partners rather than rivals during a telephone conversation on Wednesday. Wang said Beijing and the EU share positions on promoting a multipolar world, advocated resolving trade disputes through dialogue, and u…
Stellantis said it will step up price reductions on new cars in France, accelerating a program that began in late 2025. The move, announced by the head of Stellantis France, aims to rebuild vehicle sales volumes in the company's largest European market, with discounts already applied to several small car models.
Texas Instruments shares climbed 7% in premarket trading after the company issued a first-quarter outlook that topped estimates, driven by robust analog chip sales tied to AI data center buildouts. Analysts highlighted potential multi-year support from data center demand, while others warned that elevated capital spending and broader market headwin…
BofA Securities has reiterated its Buy rating on ASML and kept a EUR1,454 price target after the lithography equipment maker reported record fourth-quarter revenue of EUR9.7 billion and exceptionally strong bookings. While several top-line and cash metrics outperformed expectations, operating profit and earnings per share came in slightly below con…
RBC Capital Markets downgraded Banco Bilbao Vizcaya Argentaria (BBVA) to Sector Perform from Outperform, citing a stretched valuation despite strong operating metrics. The brokerage raised its price target to €19.75 but sees limited upside from current levels and shifted its preference to Banco Santander (SAN).
Wells Fargo's wealth and investment management division has cut ties with the proxy advisory firm Institutional Shareholder Services (ISS) and will shift to making voting decisions on shareholder proposals using a newly developed in-house process. The move follows similar recent changes among large asset managers and comes amid intensified scrutiny…
Walmart has reclassified 3,000 pharmacy technician roles into operations team lead positions and raised average hourly pay from $22 to $28. The move, which also makes technicians eligible for wages up to $40.50 and gives team leads potential pay up to $42 an hour (excluding bonuses), is part of a broader expansion of the company's digital and pharm…
Eikon Therapeutics has filed for a U.S. initial public offering that would value the company at as much as $908.2 million. The Millbrae, California-based drug developer plans to sell 17.65 million shares at $16 to $18 apiece, aiming to raise up to $317.7 million and list on the Nasdaq under the symbol EIKN as the biotech IPO pipeline gains momentum…
Baird has launched coverage of Coinbase Global Inc. (COIN) with a Neutral rating and a $240 price target, citing the company's leading U.S. exchange franchise, strong recent revenue growth and a number of growth initiatives. The firm said risk and reward appear balanced given recent trading-volume deterioration and regulatory uncertainty, while oth…
Citizens reiterated a Market Outperform rating and a $115 price target on eBay, citing stronger-than-expected gross merchandise volume (GMV) trends in collectibles and luxury resale. The firm expects eBay to beat Q4 2025 GMV estimates and projects at least mid-single-digit GMV growth in 2026, driven by product enhancements and ongoing recommerce de…
Cantor Fitzgerald upgraded Korro Bio Inc. (KRRO) from Neutral to Overweight and set a $21.00 price target, pointing to robust preclinical evidence, a clear clinical development plan and the market opportunity for KRRO-121 in urea cycle disorders and hepatic encephalopathy. The stock, trading near $10.74, has climbed 13.41% over the past week. Korro…
